List of Tables
Table 1. Global Dutasteride Drug Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Dutasteride Drug Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Dutasteride Drug Market Competitive Situation by Manufacturers in 2025
Table 4. Global Dutasteride Drug Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Dutasteride Drug Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Dutasteride Drug Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Dutasteride Drug Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Dutasteride Drug Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Dutasteride Drug, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Dutasteride Drug, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Dutasteride Drug, Product Types and Applications
Table 12. Global Key Manufacturers of Dutasteride Drug, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Dutasteride Drug Companies by Tier (Tier 1, Tier 2, Tier 3), based on Dutasteride Drug Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Dutasteride Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Dutasteride Drug Sales by Region (K Units), 2021–2026
Table 18. Global Dutasteride Drug Sales Market Share by Region (2021–2026)
Table 19. Global Dutasteride Drug Sales by Region (K Units), 2027–2032
Table 20. Global Dutasteride Drug Sales Market Share by Region (2027–2032)
Table 21. Global Dutasteride Drug Revenue by Region (US$ Million), 2021–2026
Table 22. Global Dutasteride Drug Revenue Market Share by Region (2021–2026)
Table 23. Global Dutasteride Drug Revenue by Region (US$ Million), 2027–2032
Table 24. Global Dutasteride Drug Revenue Market Share by Region (2027–2032)
Table 25. North America Dutasteride Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Dutasteride Drug Sales by Country (K Units), 2021–2026
Table 27. North America Dutasteride Drug Sales by Country (K Units), 2027–2032
Table 28. North America Dutasteride Drug Revenue by Country (US$ Million), 2021–2026
Table 29. North America Dutasteride Drug Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Dutasteride Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Dutasteride Drug Sales by Country (K Units), 2021–2026
Table 32. Europe Dutasteride Drug Sales by Country (K Units), 2027–2032
Table 33. Europe Dutasteride Drug Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Dutasteride Drug Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Dutasteride Drug Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Dutasteride Drug Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Dutasteride Drug Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Dutasteride Drug Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Dutasteride Drug Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Dutasteride Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Dutasteride Drug Sales by Country (K Units), 2021–2026
Table 42. Latin America Dutasteride Drug Sales by Country (K Units), 2027–2032
Table 43. Latin America Dutasteride Drug Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Dutasteride Drug Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Dutasteride Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Dutasteride Drug Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Dutasteride Drug Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Dutasteride Drug Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Dutasteride Drug Revenue by Country (US$ Million), 2027–2032
Table 50. Global Dutasteride Drug Sales (K Units) by Type (2021–2026)
Table 51. Global Dutasteride Drug Sales (K Units) by Type (2027–2032)
Table 52. Global Dutasteride Drug Sales Market Share by Type (2021–2026)
Table 53. Global Dutasteride Drug Sales Market Share by Type (2027–2032)
Table 54. Global Dutasteride Drug Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Dutasteride Drug Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Dutasteride Drug Revenue Market Share by Type (2021–2026)
Table 57. Global Dutasteride Drug Revenue Market Share by Type (2027–2032)
Table 58. Global Dutasteride Drug Price (US$/Unit) by Type (2021–2026)
Table 59. Global Dutasteride Drug Price (US$/Unit) by Type (2027–2032)
Table 60. Global Dutasteride Drug Sales (K Units) by Application (2021–2026)
Table 61. Global Dutasteride Drug Sales (K Units) by Application (2027–2032)
Table 62. Global Dutasteride Drug Sales Market Share by Application (2021–2026)
Table 63. Global Dutasteride Drug Sales Market Share by Application (2027–2032)
Table 64. Global Dutasteride Drug Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Dutasteride Drug Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Dutasteride Drug Revenue Market Share by Application (2021–2026)
Table 67. Global Dutasteride Drug Revenue Market Share by Application (2027–2032)
Table 68. Global Dutasteride Drug Price (US$/Unit) by Application (2021–2026)
Table 69. Global Dutasteride Drug Price (US$/Unit) by Application (2027–2032)
Table 70. GSK Company Information
Table 71. GSK Description and Business Overview
Table 72. GSK Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. GSK Dutasteride Drug Product
Table 74. GSK Recent Developments/Updates
Table 75. Waylis Therapeutics Company Information
Table 76. Waylis Therapeutics Description and Business Overview
Table 77. Waylis Therapeutics Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Waylis Therapeutics Dutasteride Drug Product
Table 79. Waylis Therapeutics Recent Developments/Updates
Table 80. Endo Company Information
Table 81. Endo Description and Business Overview
Table 82. Endo Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Endo Dutasteride Drug Product
Table 84. Endo Recent Developments/Updates
Table 85. Zydus Company Information
Table 86. Zydus Description and Business Overview
Table 87. Zydus Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Zydus Dutasteride Drug Product
Table 89. Zydus Recent Developments/Updates
Table 90. Aurobindo Pharma Company Information
Table 91. Aurobindo Pharma Description and Business Overview
Table 92. Aurobindo Pharma Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Aurobindo Pharma Dutasteride Drug Product
Table 94. Aurobindo Pharma Recent Developments/Updates
Table 95. Barr Pharmaceuticals Company Information
Table 96. Barr Pharmaceuticals Description and Business Overview
Table 97. Barr Pharmaceuticals Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Barr Pharmaceuticals Dutasteride Drug Product
Table 99. Barr Pharmaceuticals Recent Developments/Updates
Table 100. Chartwell Company Information
Table 101. Chartwell Description and Business Overview
Table 102. Chartwell Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Chartwell Dutasteride Drug Product
Table 104. Chartwell Recent Developments/Updates
Table 105. Amneal Pharmaceuticals Company Information
Table 106. Amneal Pharmaceuticals Description and Business Overview
Table 107. Amneal Pharmaceuticals Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Amneal Pharmaceuticals Dutasteride Drug Product
Table 109. Amneal Pharmaceuticals Recent Developments/Updates
Table 110. Strides Pharma Company Information
Table 111. Strides Pharma Description and Business Overview
Table 112. Strides Pharma Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Strides Pharma Dutasteride Drug Product
Table 114. Strides Pharma Recent Developments/Updates
Table 115. Acella Pharmaceuticals Company Information
Table 116. Acella Pharmaceuticals Description and Business Overview
Table 117. Acella Pharmaceuticals Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Acella Pharmaceuticals Dutasteride Drug Product
Table 119. Acella Pharmaceuticals Recent Developments/Updates
Table 120. Ascent Pharmaceuticals Company Information
Table 121. Ascent Pharmaceuticals Description and Business Overview
Table 122. Ascent Pharmaceuticals Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Ascent Pharmaceuticals Dutasteride Drug Product
Table 124. Ascent Pharmaceuticals Recent Developments/Updates
Table 125. Humanwell Puracap Company Information
Table 126. Humanwell Puracap Description and Business Overview
Table 127. Humanwell Puracap Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Humanwell Puracap Dutasteride Drug Product
Table 129. Humanwell Puracap Recent Developments/Updates
Table 130. Sichuan Gowell Pharmaceutical Company Information
Table 131. Sichuan Gowell Pharmaceutical Description and Business Overview
Table 132. Sichuan Gowell Pharmaceutical Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Sichuan Gowell Pharmaceutical Dutasteride Drug Product
Table 134. Sichuan Gowell Pharmaceutical Recent Developments/Updates
Table 135. Chengdu Suncadia Medicine Company Information
Table 136. Chengdu Suncadia Medicine Description and Business Overview
Table 137. Chengdu Suncadia Medicine Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Chengdu Suncadia Medicine Dutasteride Drug Product
Table 139. Chengdu Suncadia Medicine Recent Developments/Updates
Table 140. Qilu Pharmaceutical Company Information
Table 141. Qilu Pharmaceutical Description and Business Overview
Table 142. Qilu Pharmaceutical Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Qilu Pharmaceutical Dutasteride Drug Product
Table 144. Qilu Pharmaceutical Recent Developments/Updates
Table 145. Jiangsu Wangao Pharmaceutical Company Information
Table 146. Jiangsu Wangao Pharmaceutical Description and Business Overview
Table 147. Jiangsu Wangao Pharmaceutical Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Jiangsu Wangao Pharmaceutical Dutasteride Drug Product
Table 149. Jiangsu Wangao Pharmaceutical Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Dutasteride Drug Distributors List
Table 153. Dutasteride Drug Customers List
Table 154. Dutasteride Drug Market Trends
Table 155. Dutasteride Drug Market Drivers
Table 156. Dutasteride Drug Market Challenges
Table 157. Dutasteride Drug Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of Dutasteride Drug
Figure 2. Global Dutasteride Drug Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Dutasteride Drug Market Share by Type: 2025 & 2032
Figure 4. Single Drug Product Picture
Figure 5. Combination Preparation Product Picture
Figure 6. Global Dutasteride Drug Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Dutasteride Drug Market Share by Application: 2025 & 2032
Figure 8. Hospital Pharmacy
Figure 9. Retail Pharmacy
Figure 10. Online Pharmacy
Figure 11. Global Dutasteride Drug Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Dutasteride Drug Market Size (US$ Million), 2021–2032
Figure 13. Global Dutasteride Drug Sales (K Units), 2021–2032
Figure 14. Global Dutasteride Drug Average Price (US$/Unit), 2021–2032
Figure 15. Dutasteride Drug Report Years Considered
Figure 16. Dutasteride Drug Sales Share by Manufacturers in 2025
Figure 17. Global Dutasteride Drug Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Dutasteride Drug Players: Market Share by Revenue in Dutasteride Drug in 2025
Figure 19. Dutasteride Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Dutasteride Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Dutasteride Drug Sales Market Share by Country (2021–2032)
Figure 22. North America Dutasteride Drug Revenue Market Share by Country (2021–2032)
Figure 23. United States Dutasteride Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Dutasteride Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Dutasteride Drug Sales Market Share by Country (2021–2032)
Figure 26. Europe Dutasteride Drug Revenue Market Share by Country (2021–2032)
Figure 27. Germany Dutasteride Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Dutasteride Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Dutasteride Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Dutasteride Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Dutasteride Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Dutasteride Drug Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Dutasteride Drug Revenue Market Share by Region (2021–2032)
Figure 34. China Dutasteride Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Dutasteride Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Dutasteride Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Dutasteride Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Dutasteride Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Dutasteride Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Dutasteride Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Dutasteride Drug Sales Market Share by Country (2021–2032)
Figure 42. Latin America Dutasteride Drug Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Dutasteride Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Dutasteride Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Dutasteride Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Dutasteride Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Dutasteride Drug Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Dutasteride Drug Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Dutasteride Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Dutasteride Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Dutasteride Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Dutasteride Drug by Type (2021–2032)
Figure 53. Global Revenue Market Share of Dutasteride Drug by Type (2021–2032)
Figure 54. Global Dutasteride Drug Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Dutasteride Drug by Application (2021–2032)
Figure 56. Global Revenue Market Share of Dutasteride Drug by Application (2021–2032)
Figure 57. Global Dutasteride Drug Price (US$/Unit) by Application (2021–2032)
Figure 58. Dutasteride Drug Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
